Planta Med 2002; 68(2): 128-132
DOI: 10.1055/s-2002-20246
Original Paper
Pharmacology
© Georg Thieme Verlag Stuttgart · New York

Different Effects of Baicalein, Baicalin and Wogonin on Mitochondrial Function, Glutathione Content and Cell Cycle Progression in Human Hepatoma Cell Lines

Wen-Huei Chang1 , Ching-Hsein Chen1 , Fung-Jou Lu1
  • 1Graduate Institute of Biochemistry and Molecular Biology, College of Medicine, National Taiwan University, Taipei, Taiwan, R.O.C.
Further Information

Publication History

February 12, 2001

June 3, 2001

Publication Date:
22 February 2002 (online)

Abstract

The effects of the flavonoids from Scutellaria baicalensis Georgi (baicalein, baicalin and wogonin) in cultured human hepatoma cells (Hep G2, Hep 3B and SK-Hep1) were compared by MTT assay and flow cytometry. All three flavonoids dose-dependently decreased the cell viabilities accompanying the collapse of mitochondrial membrane potential and the depletion of glutathione content. However, the influence of baicalein, baicalin or wogonin on cell cycle progression was different. All three flavonoids resulted in prominent increase of G2/M population in Hep G2 cells, whereas an accumulation of sub G1 (hypoploid) peak in Hep 3B cells was observed. In SK-Hep1 cells, baicalein and baicalin resulted in dramatic boost in hypoploid peak, but wogonin made mainly in G1 phase accumulation. These data, together with the previous findings in other hepatoma cell lines, suggest that baicalein, baicalin and wogonin might be effective candidates for inducing apoptosis or inhibiting proliferation in various human hepatoma cell lines.

References

  • 1 Bosch F X. Global epidemiology of hepatocellular carcinoma. In : Okuda K, Tabor E, editors Liver cancer. New York; Churchill Livingstone 1997: 13-28
  • 2 Akriviadis E A, Llovet J M, Efremidis S C, Shouval D, Canelo R, Ringe B, Meyers W C. Hepatocellular carcinoma.  The British Journal of Surgery. 1998;  85 1319-31
  • 3 Chiu H, Lin C C, Yang C C, Yang F. The pharmacological and pathological studies on several hepatic protective crude drugs from Taiwan (II).  American Journal of Chinese Medicine. 1989;  17 17-23
  • 4 Tatsuta M, Takemoto N, Maruyama N, Nakaizumi A, Uehara H. Inhibition by xiao-chai-hu-tang (TJ-9) of development of hepatic foci induced by N-nitrosomorpholine in Sprague-Dawley rats.  Japanese Journal of Cancer Research. 1991;  82 987-92
  • 5 Yano H, Mizoguchi A, Fukuda K, Haramaki M, Ogasawara S, Momosaki S, Kojiro M. The herbal medicine Sho-saiko-to inhibits proliferation of cancer cell lines by inducing apoptosis and arrest at the G0/G1 phase.  Cancer Research. 1994;  54 448-54
  • 6 Kubo M, Kimura Y, Odani T, Tani T, Namba K. Studies on Scutellaria radix. II : The antibacterial substance.  Planta Medica. 1981;  43 194-201
  • 7 Chung C P, Park J B, Bae K H. Pharmacological effects of methanolic extract from the root of Scutellaria baicalensis and its flavonoids on human gingival fibroblast.  Planta Medica. 1991;  61 150-3
  • 8 Huang R L, Chen C C, Huang H L, Chang C G, Chen C F, Chang C M, Hsieh M T. Anti-hepatitis B virus effects of wogonin isolated from Scutellaria baicalensis .  Planta Medica. 2000;  66 694-8
  • 9 Okita K, Li Q, Murakami T, Takahashi M. Anti-growth effects with components of Sho-saiko-to (TJ-9) on cultured human hepatoma cells.  European Journal of Cancer Prevention. 1993;  2 169-76
  • 10 Gao Z, Huang K, Yang H, Xu H. Free radical scavenging and antioxidant activities of flavonoids extracted from the radix of Scutellaria baicalensis Georgi.  Biochimica et Biophysica Acta. 1999;  1472 643-50
  • 11 Rust C, Gores G J. Apoptosis and liver disease.  The American Journal of Medicine. 2000;  108 567-74
  • 12 Thompson C B. Apoptosis in the pathogenesis and treatment of disease.  Science. 1995;  267 1456-62
  • 13 Green D. Apoptotic pathways: the roads to ruin.  Cell. 1998;  94 695-8
  • 14 Zamzami N, Marchetti P, Castedo M, Zanin C, Vayssiere J L, Petit P X, Kroemer G. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo .  Journal of Experimental Medicine. 1995;  181 1661-72
  • 15 Carmichael J, DeGraff W G, Gazdar A F, Minna J D, Mitchell J B. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing.  Cancer Research. 1987;  47 936-42
  • 16 Reader S, Marion M, Denizeau F. Flow cytomertic analysis of the effects of tri-n-butylin chloride on cytosolic free calcium and thiol levels in isolated rainbow trout hepatocytes.  Toxicology. 1993;  80 117-29
  • 17 Carson D A, Lois A. Cancer progression and p53.  The Lancet. 1995;  346 1009-11
  • 18 Bressac B, Galvin K M, Liang T J, Isselbacher K J, Wands J R, Ozturk M. Abnormal structure and expression of p53 gene in human hepatocellular carcinoma.  Proceeding of the National Academy of Science of the United States of America. 1990;  87 1973-7
  • 19 Bunz F, Hwang P M, Torrance C, Waldman T, Zhang Y, Dillehay L, Williams J, Lengauer C, Kinzler K W, Vogelstein B. Disruption of p53 in human cancer cells alters the responses to therapeutic agents.  The Journal of Clinical Investigation. 1999;  104 263-9
  • 20 Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown J P, Sedivy J M, Kinzler K W, Vogelstein B. Requirement for p53 and p21 to sustain G2 arrest after DNA damage.  Science. 1998;  282 1497-501

Dr. Fung-Jou Lu

Department of Biochemistry

College of Medicine

National Taiwan University

No. 1, Sec 1, Jen-Ai Road

Taipei 100

Taiwan, R.O.C.

Email: fujulu@ha.mc.ntu.edu.tw

Fax: +886-2-23214559

    >